Ispire's Stock Trading Volume Decreases 51% on November 5th

Business by 2FIRSTS.ai

Dec.06.2023

Ispire's Stock Trading Volume Decreases 51% on November 5th

Ispire (ISPR) stock trades strong with a volume of 35,318 shares, down 51% from the previous day.

According to a report by Rivertonroll on December 5th, the trading volume of Ispire (Ispire Technology Inc., Nasdaq stock code: ISPR) was strong on November 5th. During the trading period, a total of 35,318 shares were traded, a decrease of 51% compared to the previous trading day's volume of 72,489 shares. The stock ended at a trading price of $9.92, up from the previous closing price of $9.85.

The stock's 50-day simple moving average is $9.79, while its 200-day simple moving average is $9.28.

References:

[1] Ispire Technology (NASDAQ:ISPR) Sees Large Volume Increase

Also Read:

[1] Ispire Technology Inc Shares Plummet 6.5% on Nasdaq

[2] Ispire's Stock Trading Volume Decreases 51% on November 5th

[3] Ispire's Stock Price Declines by 3.1% on E-Cigarette Market

#North America #United States #Market #Technology.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

NZ Issues National High Alert on Etomidate-Laced Vapes After Hospitalisations

New Zealand’s High Alert drug harm monitoring system has issued a public High Alert warning after multiple hospitalisations linked to illicit vape pods containing the anaesthetic etomidate. Known on the street as space oil, k-pods, or eto, these vapes were first detected in January 2025. Customs has since seized additional samples, and clinics nationwide report rising cases of poisoning and hypoglycaemia.

Nov.04 by 2FIRSTS.ai

Morocco Lawmakers Propose Excise Taxes on Vapes, Hookah, and Nicotine Alternatives

Members of the Socialist Union of Popular Forces (USFP) have submitted amendments to Article 7 of the Finance Bill, introducing new excise taxes on e-cigarette liquids, hookah accessories, and non-tobacco nicotine products. The proposal also revises VAT exemptions and insurance tax rates to enhance fiscal fairness and revenue clarity.

Nov.11 by 2FIRSTS.ai

FDA CTP Acting Director Supports Expanding Authorized Flavored E-Cigs and Legal Marketplace

At the FDLI Tobacco and Nicotine Policy Conference, FDA CTP Acting Director Bret Koplow spoke in favor of promoting tobacco harm reduction to reduce smoking. He backed a legal marketplace for authorized reduced-risk products, potential expansion of flavored e-cigs, and faster FDA reviews to ensure a strong, regulated market.

Oct.29 by 2FIRSTS.ai

FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection

In an interview with CNN’s Chasing Life, U.S. Food and Drug Administration (FDA) Commissioner Dr. Marty Makary warned that new health risks — from emerging opioids such as 7-OH to unregulated vaping products — are slipping through regulatory cracks. His remarks reveal the FDA’s growing challenge to balance harm reduction for adult smokers with youth protection and cross-border enforcement.